Dow Down 0.25% Nasdaq Down 0.14%

Gilead Sciences Inc. (GILD)

-NasdaqGS
107.51 0.87(0.80%) Sep 29, 4:15PM EDT
|Pre-Market : 107.87 Up 0.36 (0.33%) 8:45AM EDT - Nasdaq Real Time Price
Prev Close:108.38
Open:107.57
Bid:107.88 x 100
Ask:107.99 x 100
1y Target Est:113.65
Beta:0.95
Earnings Date:Oct 28 - Oct 31 (Est.)
Day's Range:106.45 - 108.68
52wk Range:58.81 - 110.64
Volume:8,086,008
Avg Vol (3m):13,675,000
Market Cap:162.52B
P/E (ttm):24.36
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.80%162.52B
GSK111.19B
PFE188.77B
RHHBY250.73B

Key Statistics

Forward P/E (1 yr):11.30
P/S (ttm):9.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.04
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback